The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $727,774 in first-year total cost, median $224,847.
Most frequent study sections
- Special Emphasis Panel[ZRG1 GGG-L (50)]3
Most frequent institutions
- ACTIVE MOTIF, INC.1
- BIOSPYDER TECHNOLOGIES, INC.1
- EPICYPHER, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Epi-seq: Multiplexed ChIP-seq for personalized medicine and drug discovery1R44HG010237-01 | JELINEK, MARY ANNE | ACTIVE MOTIF, INC., CA | $279,395 | ZRG1 |
| 2018 | TempO-Seq Profiling of RNA Epitranscriptomic Modifications1R44HG009763-01A1 | SELIGMANN, BRUCE E. | BIOSPYDER TECHNOLOGIES, INC., CA | $223,532 | ZRG1 |
| 2017 | Next-Generation Detection Reagents for Chromatin Immunoprecipitation1R43HG009768-01 | KEOGH, MICHAEL-CHRISTOPHER | EPICYPHER, INC., NC | $224,847 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.